Form 8-K - Current report:
SEC Accession No. 0001193125-25-134103
Filing Date
2025-06-03
Accepted
2025-06-03 16:01:19
Documents
12
Period of Report
2025-06-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d38717d8k.htm   iXBRL 8-K 32510
  Complete submission text file 0001193125-25-134103.txt   146477

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dawn-20250602.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20250602_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20250602_pre.xml EX-101.PRE 11265
14 EXTRACTED XBRL INSTANCE DOCUMENT d38717d8k_htm.xml XML 3654
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 251019232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)